Drug intelligence / Profile preview

d-eritadenine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

D-Eritadenine is a naturally occurring purine alkaloid found in shiitake mushrooms (Lentinula edodes) and other fungi. It is an adenosine analog and a member of the 6-aminopurines class. D-Eritadenine acts as a potent, reversible inhibitor of S-adenosyl-L-homocysteine hydrolase (SAHH), an enzyme involved in methylation reactions within cells[2][4][5][8]. Through this inhibition, D-eritadenine can disrupt methylation-dependent biological processes. The compound has demonstrated hypocholesterolemic activity in animal studies by altering liver phospholipid metabolism, leading to enhanced removal or reduced release of cholesterol from the liver[5][10]. Its mechanism for lowering cholesterol does not involve direct inhibition of cholesterol biosynthesis but rather modulation of lipid handling by the liver. D-Eritadenine has also shown antiviral properties due to its SAHH inhibitory action[8]. There are no approved pharmaceutical uses for D-eritadenine; it remains primarily an experimental compound studied for its biochemical effects.

Other names
eritadeninelentinacinlentysineleutinacind-erythro-eritadenine4-(9-Adenyl)-D-erythro-2,3-dihydroxybutyric acid
02

Targets

AHCY (S-adenosylhomocysteine hydrolase)

Beyond the preview

Go deeper on d-eritadenine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on d-eritadenine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call